# Trump Reclassifies State-Licensed Medical Cannabis, but It's Not Legal Just Yet
The Trump administration has moved to reclassify state-licensed medical cannabis, marking a shift in federal drug policy. However, this reclassification does not automatically make cannabis legal at the federal level, and the process remains incomplete.
The reclassification affects how the federal government categorizes cannabis in states where it operates legally under state law. Previously, cannabis held Schedule I status under the Controlled Substances Act, placing it in the same category as heroin and LSD. This new classification reflects growing recognition that medical cannabis has legitimate therapeutic uses in states with regulated programs.
For families navigating medical cannabis for children with specific conditions like severe epilepsy, this reclassification offers modest progress. Some pediatric patients use cannabis-derived compounds such as CBD oil or whole-plant extracts under state medical programs. The reclassification may eventually reduce barriers to research and pharmaceutical development of cannabis-based medicines.
Parents should understand the distinction between reclassification and legalization. Reclassification changes how the federal government views cannabis but does not eliminate the legal gray zone. Medical cannabis remains federally illegal, which means banking, insurance, and interstate commerce remain complicated. Families in states with medical programs still operate under state protections that don't shield them from potential federal enforcement.
This also doesn't change what pediatricians can prescribe. Federal rules still restrict doctors from recommending cannabis, though some states allow physicians to authorize its use. Parents considering cannabis for children should consult their state's regulations and speak with their pediatrician about available options and evidence.
The reclassification signals momentum toward federal recognition of cannabis's medical value. Full legalization or removal from controlled substance schedules would require Congressional action. Until then, families should verify their state's specific rules, understand that protections vary by location,